Clinical Trials Directory

Trials / Conditions / Adenocarcinoma of the Gallbladder

Adenocarcinoma of the Gallbladder

6 registered clinical trials studyying Adenocarcinoma of the Gallbladder.

StatusTrialSponsorPhase
WithdrawnSelumetinib and Akt Inhibitor MK-2206 in Treating Patients With Refractory or Advanced Gallbladder or Bile Duc
NCT01859182
National Cancer Institute (NCI)Phase 2
CompletedGenotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointest
NCT01643499
University of ChicagoPhase 1
TerminatedTrastuzumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer or Bile Duct Cancer Th
NCT00478140
National Cancer Institute (NCI)Phase 2
CompletedS0514 Sorafenib in Treating Patients With Unresectable or Metastatic Gallbladder Cancer or Cholangiocarcinoma
NCT00238212
National Cancer Institute (NCI)Phase 2
TerminatedBortezomib in Treating Patients With Unresectable Locally Advanced or Metastatic Adenocarcinoma of the Bile Du
NCT00085410
National Cancer Institute (NCI)Phase 2
CompletedVaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
NCT00028496
National Cancer Institute (NCI)Phase 1